Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (221-230 of 325) with videos related to

Pageof 33
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2012
Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in ZimbabweAndrea L Ciaranello, Freddy Perez, Barbara Engelsmann, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2017
Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South AfricaIngrid V Bassett, Sharon M Coleman, Janet Giddy, et al.
BMJ Global Health|December 15, 2024
The impact of tobacco smoking and smoking cessation on lung cancer and stroke incidence among people with HIV on antiretroviral therapy in South Africa: a simulation modeling studyHelen D'Couto, Acadia M Thielking, Ronel Sewpaul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2016
Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel StrategiesEric N Ouattara, Marion Robine, Serge P Eholié, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapyRochelle P Walensky, Sue J Goldie, Paul E Sax, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regional analysisAndrea Ciaranello, Zhigang Lu, Samuel Ayaya, et al.
AIDS (London, England)|February 5, 2011
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello, Shahin Lockman, Kenneth A Freedberg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patientsKenneth A Freedberg, Lisa R Hirschhorn, Bruce R Schackman, et al.
Travel Medicine and Infectious Disease|June 3, 2024
Modeling approaches to inform travel-related policies for COVID-19 containment: A scoping review and future directionsSatoshi Koiso, Eren Gulbas, Lotanna Dike, et al.
Plos One|March 9, 2010
The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South AfricaElena Losina, Ingrid V Bassett, Janet Giddy, et al.
Pageof 33

Showing results (221-230 of 325) with videos related to

Sort By:
Pageof 33
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2012
Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in ZimbabweAndrea L Ciaranello, Freddy Perez, Barbara Engelsmann, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2017
Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South AfricaIngrid V Bassett, Sharon M Coleman, Janet Giddy, et al.
BMJ Global Health|December 15, 2024
The impact of tobacco smoking and smoking cessation on lung cancer and stroke incidence among people with HIV on antiretroviral therapy in South Africa: a simulation modeling studyHelen D'Couto, Acadia M Thielking, Ronel Sewpaul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2016
Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel StrategiesEric N Ouattara, Marion Robine, Serge P Eholié, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapyRochelle P Walensky, Sue J Goldie, Paul E Sax, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regional analysisAndrea Ciaranello, Zhigang Lu, Samuel Ayaya, et al.
AIDS (London, England)|February 5, 2011
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello, Shahin Lockman, Kenneth A Freedberg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patientsKenneth A Freedberg, Lisa R Hirschhorn, Bruce R Schackman, et al.
Travel Medicine and Infectious Disease|June 3, 2024
Modeling approaches to inform travel-related policies for COVID-19 containment: A scoping review and future directionsSatoshi Koiso, Eren Gulbas, Lotanna Dike, et al.
Plos One|March 9, 2010
The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South AfricaElena Losina, Ingrid V Bassett, Janet Giddy, et al.
Pageof 33